Aug 4, 2026 · 28 min · 12 segments
In this episode of BioSignals, Vince Wong talks with Milan Radovich, a nationally recognized leader in cancer genomics and Precision oncology. Milan’s work sits at the forefront of translating complex…
Milan RadovichGuest
Vince WongHostWelcome to Biosignals, the podcast powered by BioCrossroads, where we decode the pulse of Indiana's life sciences sector.
Each episode, we bring you the innovators, breakthroughs, and bold ideas shaping the future of health and science.
In this episode of Biosignals, Vince Wong will sit down with Milan Radovic, a nationally recognized leader in cancer genomics and precision oncology.
Milan's work sits at the forefront of translating complex genomic data into real-world clinical insights, helping redefine how cancer is diagnosed and treated.
Milan's research has been instrumental in advancing biomarker-driven approaches, enabling more personalized and effective patient therapies.
In this conversation, we will explore how precision medicine is evolving, the challenges of turning data into action in clinical settings, and how Indiana's unique ecosystem is accelerating the path from discovery to patient impact.
We'll also discuss the future of oncology, the role of AI and data science, and what it will take to bring the next generation of therapies to patients faster.
Read the full transcript.
Create an account to read the whole episode, search across every transcript, and follow the shows you care about.
Welcome to Biosignals, the podcast powered by BioCrossroads, where we decode the pulse of Indiana's life sciences sector.
Each episode, we bring you the innovators, breakthroughs, and bold ideas shaping the future of health and science.
In this episode of Biosignals, Vince Wong will sit down with Milan Radovic, a nationally recognized leader in cancer genomics and precision oncology.
Milan's work sits at the forefront of translating complex genomic data into real-world clinical insights, helping redefine how cancer is diagnosed and treated.
Milan's research has been instrumental in advancing biomarker-driven approaches, enabling more personalized and effective patient therapies.
In this conversation, we will explore how precision medicine is evolving, the challenges of turning data into action in clinical settings, and how Indiana's unique ecosystem is accelerating the path from discovery to patient impact.
We'll also discuss the future of oncology, the role of AI and data science, and what it will take to bring the next generation of therapies to patients faster.
